Business of Medicine

From the Journals

Kymriah appears cost effective in analysis

The latest study on the CAR T therapy tisagenlecleucel for pediatric leukemia says it may be cost effective, provided that the long-term benefits...

Beyond the White Coat

How much more proof do you need?

Why are there still proponents for lengthy IV therapy when oral therapy works just as well?

Managing Your Practice

The Sunshine Act, 5 years hence

The law’s questionable impact and apparent lack of enforcement do not mean you can ignore it. The data are still being collected and displayed.

Pages